Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2016  |  Volume : 29  |  Issue : 1  |  Page : 73-78

Role of heart fatty acid-binding protein (h-FABP-type III) as a diagnostic biomarker in acute coronary syndrome


Department of Cardiology, Faculty of Medicine, Menoufia University, Menoufia, Egypt

Correspondence Address:
Mostafa A Soliman
Cairo-elsharabyia, 2husseinabdelwahab-st., 11511 Cairo
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1110-2098.178990

Rights and Permissions

Objective To determine the role of heart-type fatty acid-binding protein (h-FABP type III) as a diagnostic biomarker in acute coronary syndrome in the early detection of myocardial ischemia or myocardial necrosis (30 min to 6 h from onset of chest pain). Background Cardiac biomarkers play an important role in the diagnosis of acute coronary syndrome. Cardiac troponins have been the preferred biomarker, but because of their delayed appearance in the serum, there is still a need for reliable. h-FABP, a small (15 kDa) cytoplasmic tissue-specific protein, is mainly expressed by cardiac biomarkers. Methods and results The patients were classified into two main groups. Group I included patients who presented with ST-segment elevation myocardial infarction (STEMI, n = 25) and group II included patients who presented with non-STEMI/unstable angina (NSTEMI/UA, n = 25) within 20 min and 6 h of acute chest pain. Blood h-FABP levels were measured using a QuickSens test (semiqualitiative) and were compared with first cTn-I and creatine kinase-MB at the time of admission and second troponin 12 h from onset of chest pain. Then, according to the serum level of h-FABP, the patients were classified into two subgroups: h-FABP-positive patients and h-FABP-negative patients. The diagnostic sensitivity, specificity, and receiver operating characteristic curve were evaluated. Serum h-FABP was significantly elevated within 20 min to 6 h. In terms of the relation between h-FABP and second troponin, h-FABP showed a sensitivity of 92.59%, a specificity of 52.17%, a positive predictive value of 69.44%, a negative predictive value of 85.71%, and an accuracy of 74%. Our results showed that h-FABP was significantly higher than other biomarkers less than 6 h after the onset of chest pain. Conclusion h-FABP can be used as an early diagnostic cardiac biomarker in the early detection of patients with an acute coronary syndrome within 30 min to 6 h of onset of chest pain.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed860    
    Printed12    
    Emailed0    
    PDF Downloaded138    
    Comments [Add]    

Recommend this journal